Comparison of Denosumab versus bisphosphonates on progression-free and overall survival in newly diagnosed multiple myeloma: A new user, active comparator analysis of real-world data

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要